EVARNO Trademark

Trademark Overview

On Thursday, March 18, 2010, a trademark application was filed for EVARNO with the United States Patent and Trademark Office. The USPTO has given the EVARNO trademark a serial number of 77962401. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 16, 2013. This trademark is owned by Glaxo Group Limited. The EVARNO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
evarno

General Information

Serial Number77962401
Word MarkEVARNO
Filing DateThursday, March 18, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 16, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 22, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 23, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, September 16, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 16, 2013ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 6, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 5, 2013EXTENSION 5 GRANTED
Monday, February 4, 2013EXTENSION 5 FILED
Monday, February 4, 2013TEAS EXTENSION RECEIVED
Thursday, August 16, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 15, 2012EXTENSION 4 GRANTED
Tuesday, August 14, 2012EXTENSION 4 FILED
Tuesday, August 14, 2012TEAS EXTENSION RECEIVED
Tuesday, January 31, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 30, 2012EXTENSION 3 GRANTED
Thursday, January 26, 2012EXTENSION 3 FILED
Thursday, January 26, 2012TEAS EXTENSION RECEIVED
Tuesday, August 2, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 1, 2011EXTENSION 2 GRANTED
Wednesday, July 27, 2011EXTENSION 2 FILED
Wednesday, July 27, 2011TEAS EXTENSION RECEIVED
Tuesday, January 25, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 24, 2011EXTENSION 1 GRANTED
Wednesday, December 22, 2010EXTENSION 1 FILED
Monday, January 24, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 22, 2010TEAS EXTENSION RECEIVED
Tuesday, August 17, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 21, 2010ASSIGNED TO EXAMINER
Tuesday, June 22, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 22, 2010PUBLISHED FOR OPPOSITION
Wednesday, May 19, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 19, 2010ASSIGNED TO LIE
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 10, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 6, 2010ASSIGNED TO EXAMINER
Tuesday, March 23, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 22, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

evarno pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic